Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Sanders

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 1983
Azlocillin: a new broad spectrum penicillinC C Sanders
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamasesC C Sanders
Reviews of Infectious Diseases|May 1, 1988
Ciprofloxacin: in vitro activity, mechanism of action, and resistanceC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1992
beta-Lactamases of gram-negative bacteria: new challenges for new drugsC C Sanders
The Journal of Antimicrobial Chemotherapy|January 1, 1982
Mezlocillin: a broad spectrum penicillin highly active against gram-positive organisms and Haemophilus influenzaeC C Sanders
The Journal of Antimicrobial Chemotherapy|January 1, 1984
Inducible beta-lactamases and non-hydrolytic resistance mechanismsC C Sanders
Infection Control : IC|July 1, 1982
Inducible beta lactamases in enterobacteriaceae and Pseudomonas: problems for the new beta lactam antibioticsC C Sanders
Antimicrobial Agents and Chemotherapy|August 1, 1989
beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistanceC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Cefepime: the next generation?C C Sanders
Annals of Internal Medicine|October 15, 1991
New beta-lactams: new problems for the internistC C Sanders
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|May 1, 1983
Azlocillin: a new broad spectrum penicillinC C Sanders
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamasesC C Sanders
Reviews of Infectious Diseases|May 1, 1988
Ciprofloxacin: in vitro activity, mechanism of action, and resistanceC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1992
beta-Lactamases of gram-negative bacteria: new challenges for new drugsC C Sanders
The Journal of Antimicrobial Chemotherapy|January 1, 1982
Mezlocillin: a broad spectrum penicillin highly active against gram-positive organisms and Haemophilus influenzaeC C Sanders
The Journal of Antimicrobial Chemotherapy|January 1, 1984
Inducible beta-lactamases and non-hydrolytic resistance mechanismsC C Sanders
Infection Control : IC|July 1, 1982
Inducible beta lactamases in enterobacteriaceae and Pseudomonas: problems for the new beta lactam antibioticsC C Sanders
Antimicrobial Agents and Chemotherapy|August 1, 1989
beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistanceC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Cefepime: the next generation?C C Sanders
Annals of Internal Medicine|October 15, 1991
New beta-lactams: new problems for the internistC C Sanders
Pageof 16